Skip to content

Side by side

How the two compare across structure, mechanism studied, evidence and regulatory status, based on published research.
PURITYPEPTIDESBPC-1575mgFOR RESEARCH USE ONLYLYOPHILIZED · ≥99% HPLC

BPC-157

Synthetic pentadecapeptide derived from a gastric protein

View BPC-157
PURITYPEPTIDESTB-50010mgFOR RESEARCH USE ONLYLYOPHILIZED · ≥99% HPLC

TB-500

Synthetic peptide related to thymosin beta-4

View TB-500
BPC-157 compared with TB-500
PropertyBPC-157TB-500
ClassCytoprotective peptideExperimental regenerative peptide
Research categorytissue repair and gastrointestinal modelstissue repair
Evidence levelLowLow
Overall statusNot approved — researchNot approved — research
FDANot approvedNot approved
EMANot approvedNot approved
WADAProhibited — S0 (check current list)Prohibited — S2
Mechanism studiedBPC-157 → Fibroblasts & endothelium → VEGFR2 / NO signalling → Tissue remodellingTB-500 → G-actin binding → Cell migration → Tissue remodelling
Molecular weight1,419.5 g/mol889 g/mol
Sizes in stock5mg, 10mg10mg,
BPC-157TB-500Tissue Repair

Where the research overlaps

Both compounds are studied within Tissue Repair research. BPC-157 is classed as cytoprotective peptide, while TB-500 is experimental regenerative peptide. Evidence is rated low for BPC-157 and low for TB-500.

For a full write-up, read Research Peptide Regulations: RUO, FDA and WADA.

FOR RESEARCH USE ONLY.Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

WhatsApp